Comprehensive Step-by-Step Approach to Acute Pain Management

Step 1: Rapid Pain Assessment and Classification

Begin by quantifying pain intensity using a 0-10 numeric rating scale, then immediately characterize the pain quality to determine the underlying mechanism. 1

Pain Characterization by Type:

Somatic nociceptive pain: Sharp, well-localized, throbbing, pressure-like (examples: post-surgical pain, bone injuries, musculoskeletal trauma) 2
Visceral nociceptive pain: Diffuse, aching, cramping, poorly localized (examples: abdominal organ distension, thoracic visceral compression) 1, 2
Neuropathic pain: Burning, sharp, shooting, electric-like (examples: diabetic neuropathy, chemotherapy-induced neuropathy, spinal stenosis, postherpetic neuralgia) 1, 2, 3

Critical Assessment Elements:

Location and radiation pattern: Document precise anatomic location and any referral patterns 1
Temporal characteristics: Onset, duration, constant vs. intermittent, predictable triggers 1
Aggravating factors: Movement, position changes, swallowing, specific activities 1
Relieving factors: Rest, position changes, prior medications tried 1

Special Population Considerations:

Cognitive impairment: Use observational tools (facial grimacing, guarding, withdrawal, vocalizations, changes in activity patterns) rather than self-report 1
Elderly patients: Assess for atypical presentations and increased vulnerability to medication adverse effects 1

Step 2: Comorbidity Assessment and Risk Stratification

Identify all comorbidities that will dictate medication selection and dosing before initiating any pharmacotherapy. 1

Renal Function:

CKD Stage 3-5 (GFR <60 mL/min): Avoid morphine, codeine, tramadol; prefer fentanyl or buprenorphine if opioids needed 1
GFR <30 mL/min: Reduce pregabalin to 25-50 mg daily with slow titration; gabapentin requires significant dose reduction 4, 5
Monitor renal function every 3-6 months as progressive decline requires further medication adjustments 5

Hepatic Disease:

Advanced liver disease: Reduce acetaminophen to <2 g/day (from standard 4 g/day); avoid duloxetine if any hepatic impairment present 1, 4
Malnutrition or severe alcohol use disorder: Lower acetaminophen doses required 6

Cardiovascular Disease:

Ischemic heart disease or arrhythmias: Avoid tricyclic antidepressants due to cardiac conduction abnormalities and QT prolongation risk 1, 5
Hypertension: NSAIDs may worsen blood pressure control; use with extreme caution 1
Patients on ACE inhibitors or diuretics: NSAIDs increase acute kidney injury risk through drug interactions 1

Gastrointestinal Risk:

History of GI bleeding or ulcers: Avoid nonselective NSAIDs; if NSAIDs essential, use COX-2 selective agents with mandatory proton pump inhibitor co-prescription 1, 6
Patients on antiplatelet therapy: NSAIDs significantly increase bleeding risk 1

Sleep Apnea:

Documented or suspected sleep apnea: Minimize or avoid opioids entirely due to respiratory depression risk; if unavoidable, use lowest effective doses with close monitoring 1

Substance Use Disorder History:

Active or prior opioid use disorder: Prioritize non-opioid multimodal analgesia; if opioids necessary for severe acute pain, prescribe minimal quantities (3-day supply maximum) with close follow-up 6
Patients on medication-assisted therapy: Continue buprenorphine or methadone; add short-acting opioids only if absolutely necessary for severe acute pain 6

Step 3: Initial Pharmacologic Management by Pain Type and Intensity

For Mild to Moderate Nociceptive Pain (Pain Score 1-6):

Start with scheduled acetaminophen 1000 mg every 6 hours (maximum 4 g/day) as the foundation. 1, 6

Add oral NSAIDs if no contraindications:

Ibuprofen 400-600 mg every 6-8 hours (maximum 2400 mg/day) 6
Naproxen 500 mg twice daily for longer duration of action 6
For localized musculoskeletal pain: Apply topical NSAIDs (diclofenac gel) to affected area four times daily instead of oral NSAIDs to minimize systemic adverse effects 6

Key principle: Acetaminophen and NSAIDs are equally effective for mild-moderate pain and should be used in combination for additive effect unless contraindicated 1

For Moderate to Severe Nociceptive Pain (Pain Score 7-10):

Initiate combination therapy with acetaminophen + NSAID + short-acting opioid for rapid pain control. 1

Opioid selection and dosing:

Oral morphine immediate-release 5-10 mg every 4 hours as first-line opioid 1
Provide rescue doses: Additional immediate-release morphine 5-10 mg every 1 hour as needed for breakthrough pain 1
Elderly patients: Start with 50% of standard opioid dose due to increased sensitivity and adverse effect risk 1
Renal impairment (GFR <30): Use fentanyl (transdermal 12.5 mcg/hour or IV) or buprenorphine instead of morphine 1

Mandatory opioid co-prescriptions:

Stimulant laxative (senna 2 tablets daily) for all patients receiving opioids to prevent constipation 1
Antiemetic (metoclopramide 10 mg three times daily or prochlorperazine 10 mg every 6 hours) for opioid-induced nausea 1

For Neuropathic Pain (Any Intensity):

NSAIDs and acetaminophen are generally ineffective for neuropathic pain; initiate neuropathic-specific agents immediately. 1, 2

First-line options (choose one):

Gabapentin: Start 300 mg at bedtime, increase by 300 mg every 3 days to target dose of 1800-3600 mg/day divided three times daily 1
- Renal dosing required: Significant dose reduction needed if GFR <60 mL/min 4
Pregabalin: Start 75 mg twice daily, increase to 150 mg twice daily after 1 week (maximum 300 mg twice daily) 1, 4
- Preferred over gabapentin in renal impairment due to more predictable linear pharmacokinetics 4
- Renal dosing: Reduce to 25-50 mg daily in CKD stage 3 with very slow titration 5
Duloxetine: Start 30 mg once daily for 1 week to minimize nausea, then increase to 60 mg once daily 1, 4
- Effective for diabetic peripheral neuropathy specifically 4
- Contraindicated in hepatic impairment; use with caution if GFR <30 mL/min 4
For localized peripheral neuropathic pain: Apply lidocaine 5% patches to affected area for 12-18 hours daily 1, 4, 5
- Safest option in elderly with multiple comorbidities due to minimal systemic absorption 5

Second-line neuropathic agents if first-line inadequate:

Nortriptyline or desipramine (secondary amine TCAs): Start 10-25 mg at bedtime, increase every 3-5 days to 50-100 mg at bedtime 1, 4
Avoid in cardiovascular disease, elderly >40 years without screening ECG, or ventricular conduction abnormalities 1, 5

For acute severe neuropathic pain requiring rapid relief:

Add short-acting opioid (morphine IR 5-10 mg every 4 hours) during titration of first-line neuropathic agent to therapeutic dose 1
Taper and discontinue opioid once neuropathic agent reaches effective dose (typically 2-4 weeks) 1

Step 4: Non-Pharmacologic Therapies (Initiate Simultaneously)

Integrate non-pharmacologic interventions from the outset rather than as afterthoughts. 1

Physical Modalities:

Ice application: 15-20 minutes every 2-3 hours for acute inflammation and swelling in first 48-72 hours 5
Heat application: After initial 72 hours for muscle relaxation and chronic pain 5
Elevation and compression: For extremity injuries to reduce edema 5

Activity Modification:

Avoid complete immobilization: Encourage gentle range-of-motion exercises within pain tolerance to prevent stiffness 5
Supervised exercise therapy: Particularly beneficial for neuropathic pain through multiple mechanisms beyond circulation improvement 5

Psychological Approaches:

Cognitive behavioral therapy: Effective for chronic pain and should be initiated early 7
Relaxation techniques and mindfulness: Can reduce pain perception and improve coping 7

Patient Education:

Set realistic expectations: Explain that complete pain elimination may not be achievable; goal is functional improvement and pain reduction to ≤3/10 1
Explain trial-and-error nature: Neuropathic pain medications require 6-8 weeks for adequate trial including 2 weeks at maximum tolerated dose 1, 4

Step 5: Monitoring Protocol and Reassessment

Reassess pain intensity and functional status at every encounter using the same 0-10 numeric scale for consistency. 1

Frequency of Reassessment:

Acute pain: Daily assessment until pain controlled, then at each follow-up visit 1
Medication titration phase: Every 3-7 days when adjusting doses 1
Stable chronic pain: Every 1-3 months 8

Treatment Success Criteria:

Substantial pain relief: Pain reduced to ≤3/10 with tolerable adverse effects → continue current regimen 1
Partial relief: Pain remains ≥4/10 after adequate trial → add second first-line agent from different class 1
Treatment failure: <30% pain reduction at target dose after adequate trial → switch to alternative first-line agent 1

Opioid-Specific Monitoring:

For all patients receiving opioids, implement structured monitoring to detect misuse early. 6

Assess for aberrant behaviors: Early refill requests, lost prescriptions, obtaining opioids from multiple providers, dose escalation without authorization 6
Monitor for oversedation: Drowsiness, confusion, slurred speech indicating excessive dosing 1
Respiratory rate monitoring: Especially critical in elderly, sleep apnea, or high-risk patients; hold dose if respiratory rate <10 breaths/minute 1
Functional assessment: Pain medication should improve function; if function declining despite pain reduction, reassess treatment plan 8

Adverse Effect Monitoring by Drug Class:

Acetaminophen:

Monitor liver function tests if doses >3 g/day or risk factors for hepatotoxicity present 6

NSAIDs:

Renal function: Check creatinine at baseline and every 3-6 months, especially in elderly or those on ACE inhibitors/diuretics 1
GI symptoms: Assess for dyspepsia, abdominal pain, melena at each visit 1
Blood pressure: Monitor for hypertension exacerbation 1

Gabapentinoids (gabapentin/pregabalin):

Sedation and dizziness: Most common in first 2 weeks; usually improves with continued use 1
Peripheral edema: Monitor for ankle swelling, especially in elderly 5
Falls risk: Screen at each visit given sedation and dizziness risk in elderly 5

Duloxetine:

Nausea: Most common in first week; improves with continued use 1
Blood pressure: Can cause small increases; monitor in hypertensive patients 1
Liver enzymes: Not routinely required but check if symptoms suggest hepatotoxicity 1

Tricyclic antidepressants:

Anticholinergic effects: Dry mouth, constipation, urinary retention, confusion (especially in elderly) 4
Orthostatic hypotension: Check orthostatic vital signs, especially in elderly 5
Cardiac monitoring: Baseline ECG required in patients >40 years; repeat if dose >100 mg/day 1

Step 6: When to Escalate or Refer

Refer to pain specialist or multidisciplinary pain center if trials of first-line medications alone and in combination fail to achieve adequate pain control. 1

Specific Referral Indications:

Inadequate response: <30% pain reduction after trials of at least 2 first-line agents at therapeutic doses for adequate duration 1
Complex pain syndromes: Mixed nociceptive and neuropathic pain requiring multimodal approach 7
Interventional procedures needed: Nerve blocks, spinal cord stimulation, intrathecal pumps 7
Suspected underlying cause requiring specialist: Impending spinal cord compression, complex regional pain syndrome 1
Substance use disorder complicating pain management: Requires addiction medicine consultation 6

Critical Pitfalls to Avoid

Never rely on pain character alone for diagnosis; always correlate with history, physical examination, and objective data. 2

Never use the term "atypical" to describe pain; instead classify as nociceptive, neuropathic, or mixed to guide treatment selection. 2

Never prescribe NSAIDs in elderly trauma patients without co-prescribing proton pump inhibitor, and avoid entirely if on antiplatelet agents or with GI bleeding history. 1

Never continue opioids long-term for neuropathic pain; they should only bridge to effective neuropathic-specific therapy. 1, 5

Never assume pain expression is uniform; recognize that women, elderly, diabetic patients, and different cultural backgrounds may present with atypical patterns. 2

Never prescribe "as needed" dosing for chronic pain; scheduled around-the-clock dosing with separate rescue doses for breakthrough pain is essential. 1

Never forget laxatives when prescribing opioids; constipation is universal and will not resolve without prophylactic treatment. 1

Help us tailor your experience